Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

NKTR, PWRM, MNTA, GRHU, VSBN - Stock Update From DrStockPick.com!

drstock-2-3

signup3m


power3

Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.

"We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now," stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. "We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger."

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

************************************

http://crwepicks.com/img/grhu_logo_137x149.jpg

GreenHouse Holdings, Inc. (OTCQB:GRHU), a leading provider of energy efficiency solutions and sustainable infrastructure products, announced that it has been engaged to utilize Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program in Gulfstream Aerospace Corporation's Long Beach, CA facility. GreenHouse is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies and complete processing of all incentives.

"Auto-DR is just one of the innovative services Greenhouse offers to help our clients reduce energy consumption by deploying state-of-the-art technology," says Rob Davis, Vice President of GreenHouse Holdings, Inc. "We are truly honored to be selected by Gulfstream and we are looking forward to the Auto-DR project as the first of many services offered in support of Gulfstream's corporate energy stewardship initiatives. This project goes to the heart of Greenhouse's mission to deliver sustainable solutions that reduce energy consumption with a positive return on investment."

GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products. The company designs, engineers and installs disparate products and technologies with visible return on investment, enabling our clients to reduce their energy costs. Our target markets for our energy efficiency solutions include residential, commercial and industrial, as well as government and military markets. In addition, we develop, design and construct rapidly deployable, sustainable infrastructure primarily for use in disaster relief and security in austere regions.

************************************

VSB Bancorp Inc. (Nasdaq:VSBN) announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share payable on January 3, 2011 to stockholders of record on December 24, 2010.

VSB Bancorp, Inc. operates as the holding company for Victory State Bank that provides commercial and retail banking services to individuals and businesses primarily in Staten Island, New York. It offers various deposit products, including interest and non-interest bearing checking, money market, NOW, savings, and time deposit accounts.

************************************

Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) announced it has completed the sale of an additional 218,647 shares of its common stock to the underwriters in connection with the underwritten public offering of 4,000,000 shares of its common stock, offered at a price of $14.35 per share.

Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs).

************************************

Nektar Therapeutics (Nasdaq:NKTR) announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.

Nektar Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology.

************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.